Effect of pre-existing anti-diphtheria toxin antibodies on T cell depletion levels following diphtheria toxin-based recombinant anti-monkey CD3 immunotoxin treatment

Transplant Immunology

Volumn 27, Issue 1, 2012, Pages 52-54

  Matar, Abraham J ^a   Pathiraja, Vimukthi ^a   Wang, Zhirui ^a   Duran Struuck, Raimon ^a   Gusha, Ashley ^a   Crepeau, Rebecca ^a   Tasaki, Masayuki ^a   Sachs, David H ^a   Huang, Christene A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antibody; Diphtheria toxin; Immunotoxin; T cell depletion

Indexed keywords

CD3 ANTIBODY; CYCLOSPORIN A; DIPHTHERIA ANTIBODY; RECOMBINANT CD3 ANTIBODY IMMUNOTOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONCENTRATION RESPONSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; REDUCED INTENSITY CONDITIONING; RHESUS MONKEY; T CELL DEPLETION; TREATMENT DURATION; VACCINATION; WHOLE BODY RADIATION;

ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; AUTOIMMUNE DISEASES; DIPHTHERIA TOXIN; IMMUNOTOXINS; LYMPHOCYTE DEPLETION; MACACA; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION IMMUNOLOGY;

EID: 84864558590     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2012.05.003     Document Type: Article

References (12)

1. Bennett M.J., Choe S., Eisenberg D. Refined structure of dimeric diphtheria toxin at 2.0 A resolution. Protein Sci 1994, 3:1444-1463.
2. Bell C.E., Eisenberg D. Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide. Biochemistry 1996, 35:1137-1149.
3. Thompson J., Hu H., Scharff J., Neville D.M.J. An anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin avoids inhibition by pre-existing antibodies in human blood. J Biol Chem 1995, 270:28037-28041.
4. Woo J.H., Lee Y.J., Neville D.M., Frankel A.E. Pharmacology of anti-CD3 diphtheria immunotoxin in CD3 positive T-cell lymphoma trials. Methods Mol Biol 2010, 651:157-175.
5. Cina R.A., Wikiel K.J., Lee P.W., Cameron A.M., Hettiarachy S., Rowland H., et al. Stable multilineage chimerism without graft versus host disease following nonmyeloablative haploidentical hematopoietic cell transplantation. Transplantation 2006, 81:1677-1685.
6. Knechtle S.J., Fechner J.H., Dong Y.C., Stavrou S., Neville D.M., Oberley T., et al. Primate renal transplants using immunotoxin. Surgery 1998, 124:438-446.
7. Knechtle S.J., Vargo D., Fechner J., Zhai Y., Wang J., Hanaway M.J., et al. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation 1997, 63:1-6.
8. Neville D.M.J., Scharff J., Hu H.Z., Rigaut K., Shiloach J., Slingerland W., et al. A new reagent for the induction of T-cell depletion, anti-CD3-CRM9. J Immunother Emphasis Tumor Immunol 1996, 19:85-92.
9. Ma S., Hu H., Thompson J., Stavrou S., Scharff J., Neville D.M.J. Genetic construction and characterization of an anti-monkey CD3 single-chain immunotoxin with a truncated diphtheria toxin. Bioconjug Chem 1997, 8:695-701.
10. Kim G.B., Wang Z., Liu Y.Y., Stavrou S., Mathias A., Goodwin K.J., et al. A fold-back single-chain diabody format enhances the bioactivity of an anti-monkey CD3 recombinant diphtheria toxin-based immunotoxin. Protein Eng Des Sel 2007, 20:425-432.
11. Woo J.H., Bour S.H., Dang T., Lee Y.J., Park S.K., Andreas E., et al. Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1). Cancer Immunol Immunother 2008, 57:1225-1239.
12. Frankel A.E., Zuckero S.L., Mankin A.A., Grable M., Mitchell K., Lee Y.J., et al. Anti-CD3 recombinant diphtheria immunotoxin therapy of cutaneous T cell lymphoma. Curr Drug Targets 2009, 10:104-109.